Global and United States Nucleic Acid Extraction Equipment Market Insights, Forecast to 2027

Robotic liquid handling technology in automated DNA extraction systems can streamline the tasks involved in extracting DNA from a sample, such as serial dilution and cherry picking.

On the basis of product

type, Med Throughput represent the largest share of the worldwide Nucleic Acid Extraction Equipment market, with 55% share. In the applications, Laboratory segment is estimated to be the largest end-use industry segment of the market, with 56% share of global market. North America holds the major share in the market, with a revenue share of 44%.

Market Analysis and Insights: Global and United States Nucleic Acid Extraction Equipment Market
This report focuses on global and United States Nucleic Acid Extraction Equipment market.
In 2020, the global Nucleic Acid Extraction Equipment market size was US$ 658.7 million and it is expected to reach US$ 1014 million by the end of 2027, with a CAGR of 6.4% during 2021-2027. In United States the Nucleic Acid Extraction Equipment market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Nucleic Acid Extraction Equipment Scope and Market Size
Nucleic Acid Extraction Equipment market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Nucleic Acid Extraction Equipment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For United States market, this report focuses on the Nucleic Acid Extraction Equipment market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in United States.


Segment by Type
Low Throughput
Med Throughput
High Throughput


Segment by Application
Hospital
Laboratory
Other


By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE


By Company
Roche Life Science
Thermo Fisher Scientific
Qiagen
PerkinElmer
LGC
Promega
Kurabo Biomedical
Bruker (Hain)
Analytik Jena
Bioneer
AutoGen
Biosan
ELITech
Genolution
GeneReach